Lazard Asset Management Portfolio holdings
AUM
$72.7B
1-Year Return
14.89%
This Quarter Return
+8.56%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$82.3B
AUM Growth
+$3.23B
(+4.1%)
Cap. Flow
-$8.69B
Cap. Flow
% of AUM
-10.56%
Top 10 Holdings %
Top 10 Hldgs %
24.03%
Holding
2,529
New
201
Increased
563
Reduced
953
Closed
424
Top Buys
| 1 |
Apple
AAPL
|
+$927M |
| 2 |
Exelon
EXC
|
+$625M |
| 3 |
Broadcom
AVGO
|
+$519M |
| 4 |
CRH
CRH
|
+$437M |
| 5 |
Marvell Technology
MRVL
|
+$283M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$839M |
| 2 |
Norfolk Southern
NSC
|
+$575M |
| 3 |
PPL Corp
PPL
|
+$355M |
| 4 |
Union Pacific
UNP
|
+$328M |
| 5 |
Cisco
CSCO
|
+$284M |
Sector Composition
| 1 | Technology | 23.46% |
| 2 | Financials | 14.23% |
| 3 | Healthcare | 13.09% |
| 4 | Industrials | 10.07% |
| 5 | Consumer Discretionary | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Genpact
G
$7.49B
| $13K | ﹤0.01% |
398
-1,625
| -80% | -$53.1K |
|
1702
VirTra
VTSI
$62.8M
| $13K | ﹤0.01% |
1,276
+908
| +247% | +$9.25K |
|
1703
TruBridge
TBRG
$299M
| $13K | ﹤0.01% |
1,440
-28
| -2% | -$253 |
|
1704
Adicet Bio
ACET
$66.9M
| $12K | ﹤0.01% |
5,409
+2,707
| +100% | +$6.01K |
|
1705
Steven Madden
SHOO
$2.22B
| $12K | ﹤0.01% |
286
-416,296
| -100% | -$17.5M |
|
1706
Travelzoo
TZOO
$103M
| $11K | ﹤0.01% |
+1,116
| New | +$11K |
|
1707
CI&T Inc
CINT
$676M
| $10K | ﹤0.01% |
+2,573
| New | +$10K |
|
1708
ResMed
RMD
$39.6B
| $10K | ﹤0.01% |
52
| – | – |
|
1709
Adverum Biotechnologies
ADVM
$69.5M
| $9K | ﹤0.01% |
700
-293
| -30% | -$3.77K |
|
1710
Conagra Brands
CAG
$9.27B
| $9K | ﹤0.01% |
325
| – | – |
|
1711
Jamf
JAMF
$1.3B
| $9K | ﹤0.01% |
+526
| New | +$9K |
|
1712
El Pollo Loco
LOCO
$303M
| $9K | ﹤0.01% |
950
-4,144
| -81% | -$39.3K |
|
1713
Pitney Bowes
PBI
$1.96B
| $9K | ﹤0.01% |
+2,102
| New | +$9K |
|
1714
ProQR Therapeutics
PRQR
$237M
| $9K | ﹤0.01% |
4,147
-1,713
| -29% | -$3.72K |
|
1715
uniQure
QURE
$959M
| $9K | ﹤0.01% |
1,958
-1,082
| -36% | -$4.97K |
|
1716
Scilex Holding
SCLX
$177M
| $9K | ﹤0.01% |
162
| – | – |
|
1717
Chegg
CHGG
$179M
| $8K | ﹤0.01% |
1,145
-383,610
| -100% | -$2.68M |
|
1718
Direct Digital Holdings
DRCT
$9.26M
| $8K | ﹤0.01% |
538
+206
| +62% | +$3.06K |
|
1719
Lineage Cell Therapeutics
LCTX
$276M
| $8K | ﹤0.01% |
6,059
-3,356
| -36% | -$4.43K |
|
1720
Abeona Therapeutics
ABEO
$335M
| $7K | ﹤0.01% |
+1,124
| New | +$7K |
|
1721
CureVac
CVAC
$1.21B
| $7K | ﹤0.01% |
2,568
-1,422
| -36% | -$3.88K |
|
|
DQ
1722
Daqo New Energy
DQ
$1.77B
| $7K | ﹤0.01% |
+279
| New | +$7K |
|
1723
Innodata
INOD
$1.85B
| $7K | ﹤0.01% |
1,064
-4,162
| -80% | -$27.4K |
|
1724
Prime Medicine
PRME
$693M
| $7K | ﹤0.01% |
1,114
-618
| -36% | -$3.88K |
|
1725
Acme United Corp
ACU
$159M
| $6K | ﹤0.01% |
147
+90
| +158% | +$3.67K |
|